Control of immune pathology by regulatory T cells

Current Opinion in Immunology

Volumn 10, Issue 6, 1998, Pages 649-655

  Mason, Don ^a   Powrie, Fiona ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN SPECIFICITY; AUTOIMMUNITY; DOWN REGULATION; ENTERITIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MUCOSAL IMMUNITY; REVIEW; T LYMPHOCYTE;

EID: 0032403697     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(98)80084-8     Document Type: Article

References (71)

1. + T cells. J Exp Med. 178:1993;237-244.
2. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol. 5:1993;1461-1471.
3. + T cells. Immunity. 1:1994;553-562.
4. + T cells. J Exp Med. 183:1996;2669-2674.
5. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. of outstanding interest Nature. 389:1997;737-742 This paper shows that IL-10 is a growth factor for T reg cells in vitro that can mediate bystander suppression in vivo.
6. Khoo UY, Proctor IE, Macpherson AJ. CD4+ T cell down-regulation in human intestinal mucosa: evidence for intestinal tolerance to luminal bacterial antigens. of special interest J Immunol. 158:1997;3626-3634 This reports that humans have T reg cells in the intestine.
7. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol. 102:1995;448-455.
8. Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. of special interest Immunol Today. 18:1997;335-343 This provides an up-to-date review.
9. Chen Y, Kuchroo VK, Inobe J-I, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
10. Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J Exp Med. 183:1996;2605-2616.
11. Haneda K, Sano K, Tamura G, Sato T, Habu S, Shirato K. TGF-beta induced by oral tolerance ameliorates experimental tracheal eosinophilia. J Immunol. 159:1997;4484-4490.
12. Weiner HL, Friedman A, Miller A, Khoury SJ, al-Sabbagh A, Santos L, Sayegh M, Nussenblatt RB, Trentham DE, Hafler DA. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol. 12:1994;809-837.
13. Ke Y, Kapp JA. Oral antigen inhibits priming of CD8+ CTL, CD4+ T cells, and antibody responses while activating CD8+ suppressor T cells. J Immunol. 156:1996;916-921.
14. + T cells in mucosal tolerance.
15. McMenamin C, Pimm C, McKersey M, Holt PG. Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells. Science. 265:1994;1869-1871.
16. McMenamin C, McKersey M, Kuhnlein P, Hunig T, Holt PG. Gamma delta T cells down-regulate primary IgE responses in rats to inhaled soluble protein antigens. J Immunol. 154:1995;4390-4394.
17. Harrison LC, Dempsey-Collier M, Kramer DR, Takahashi K. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J Exp Med. 184:1996;2167-2174.
18. Seymour BW, Gershwin LJ, Coffman RL. Aerosol-induced immunoglobulin (Ig)-E unresponsiveness to ovalbumin does not require CD8+ or T cell receptor (TCR)-gamma/delta+ T cells or interferon (IFN)-gamma in a murine model of allergen sensitization. of outstanding interest J Exp Med. 187:1998;721-731 This paper provides evidence for redundancy in mechanisms controlling IgE synthesis.
19. Saoudi A, Seddon B, Heath V, Fowell D, Mason D. The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset. Immunol Rev. 149:1996;195-216.
20. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med. 184:1996;387-396.
21. Suri-Payer E, Amar AZ, Thornton AM, Shevach EM. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol. 160:1998;1212-1218.
22. Taguchi O, Takahashi T. Administration of anti-interleukin-2 receptor alpha antibody in vivo induces localized autoimmune disease. Eur J Immunol. 26:1996;1608-1612.
23. Papiernik M, de Moraes ML, Pontoux C, Vasseur F, Penit C. Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. of special interest Int Immunol. 10:1998;371-378 The authors present evidence that regulatory T cells are not susceptible to antigen-induced intrathymic clonal deletion.
24. Hunig T, Schimpl A. Systemic autoimmune disease as a consequence of defective lymphocyte death. of special interest Curr Opin Immunol. 9:1997;826-830 This provides a comprehensive review of the role of IL-2 in immune regulation.
25. Fowell D, Mason D. Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential. J Exp Med. 177:1993;627-636.
26. Seddon B, Saoudi A, Nicholson M, Mason D. CD4+CD8-thymocytes that express L-selectin protect rats from diabetes upon adoptive transfer. Eur J Immunol. 26:1996;2702-2708.
27. Hammond KJL, Poulton LD, Palmisano LJ, Silveira PA, Godfrey DI, Baxter AG. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. of special interest J Exp Med. 187:1998;1047-1056 This paper demonstrates that the NOD mouse develops IDDM because of a lack of IL-4 and that this deficiency can be made good by NKT thymocytes which do not express L-selectin and which are deficient in these animals.
28. + - like thymocytes in the NOD mouse. Eur J Immunol. 26:1996;2989-2998.
29. Zlotnik A, Godfrey DI, Fischer M, Suda T. Cytokine production by mature and immature CD4-CD8- T cells. Alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4. J Immunol. 149:1992;1211-1215.
30. Cameron MJ, Arreaza GA, Zucker P, Chensue SW, Strieter RM, Chakrabarti S, Delovitch TL. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. of special interest J Immunol. 159:1997;4686-4692 This paper confirms the finding in reference [31], that NOD mice are protected from IDDM if provided with an exogenous source of IL-4.
31. Mueller R, Krahl T, Sarvetnick N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med. 184:1996;1093-1099.
32. Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, Porcelli S, Schatz DA, Atkinson MA, Balk SP, et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. of special interest Nature. 391:1998;177-181 This gives an indication both that many individuals who develop IDDM have abnormal CD1-restricted T cells that are deficient in IL-4 production and that the pathogenesis of diabetes in these patients is similar to that in NOD mice.
33. Modigliani Y, Coutinho A, Pereira P, Le Douarin N, Thomas-Vaslin V, Burlen-Defranoux O, Salaun J, Bandeira A. Establishment of tissue-specific tolerance is driven by regulatory T cells selected by thymic epithelium. Eur J Immunol. 26:1996;1807-1815.
34. McCullagh P. The significance of immune suppression in normal self tolerance. Immunol Rev. 149:1996;127-153.
35. Onodera K, Volk HD, Ritter T, Kupiec-Weglinski JW. Thymus requirement and antigen dependency in the 'infectious' tolerance pathway in transplant recipients. J Immunol. 160:1998;5765-5772.
36. Waldmann H, Cobbold S. How do monoclonal antibodies induce tolerance? A role for infectious tolerance? of special interest Annu Rev Immunol. 16:1998;619-644 This is a thorough review on antibody-induced tolerance.
37. Taguchi O, Nishizuka Y. Self tolerance and localized autoimmunity. Mouse models of autoimmune disease that suggest tissue-specific suppressor T cells are involved in self tolerance. J Exp Med. 165:1987;146-156.
38. Bemelman F, Honey K, Adams E, Cobbold S, Waldmann H. Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. of special interest J Immunol. 160:1998;2645-2648 This paper illustrates the transition from tolerance depending on clonal deletion - at high levels of bone marrow chimerism - to one depending on T reg cells at low levels of chimerism.
39. Kumar V, Stellrecht K, Sercarz E. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE). J Exp Med. 184:1996;1609-1617.
40. Ablamunits V, Elias D, Reshef T, Cohen IR. Islet T cells secreting IFN-gamma in NOD mouse diabetes: arrest by p277 peptide treatment. J Autoimmun. 11:1998;73-81.
41. van Eden W, van der Zee R, Paul AG, Prakken BJ, Wendling U, Anderton SM, Wauben MH. Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases? of special interest Immunol Today. 19:1998;303-307 This proposes a provocative hypothesis that might explain how bacterial flora modify susceptibility to autoimmunity.
42. O'Garra A, Steinman L, Gijbels K. CD4+ T-cell subsets in autoimmunity. of special interest Curr Opin Immunol. 9:1997;872-883 This is a useful review that makes the point that the Th1/Th2 dichotomy is not a satisfactory explanation for self tolerance that is mediated by T reg cells.
43. Saoudi A, Seddon B, Fowell D, Mason D. The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients. J Exp Med. 184:1996;2393-2398.
44. Heath V, Mason D, Ramirez F, Seddon B. Homeostatic mechanisms in the control of autoimmunity. Semin Immunol. 9:1997;375-380.
45. Williams CB, Vidal K, Donermeyer D, Peterson DA, White JM, Allen PM. In vivo expression of a TCR antagonist: T cells escape central tolerance but are antagonized in the periphery. of outstanding interest J Immunol. 161:1998;128-137 This report shows that T cells recognising a peptide as an antagonist are not deleted by that peptide in the thymus but respond to it as an antagonist in the periphery. It suggests a possible role for self antagonist peptides in the control of autoimmunity.
46. Santos LM, al-Sabbagh A, Londono A, Weiner HL. Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice. Cell Immunol. 157:1994;439-447.
47. Gonnella PA, Chen Y, Inobe J, Komagata Y, Quartulli M, Weiner HL. In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice. of special interest J Immunol. 160:1998;4708-4718 The authors provide a quantitative analysis of the induction of cytokines in vivo.
48. Marth T, Strober W, Kelsall BL. High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. J Immunol. 157:1996;2348-2357.
49. Tonkonogy SL, Swain SL. Distinct lymphokine production by CD4+ T cells isolated from mucosal and systemic lymphoid organs. Immunology. 80:1993;574-580.
50. Seder RA, Marth T, Sieve MC, Strober W, Letterio JJ, Roberts AB, Kelsall B. Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. of special interest J Immunol. 160:1998;5719-5728 This paper describes experiments in vitro on the cytokines that induce TGF-β.
51. Foulkes R, Shaw S, Suitters A. Immunological consequences of inhibiting dehydroepiandosterone (DHEA) sulfatase in vivo. of special interest Rook GAW, Lightman S. Steroid Hormones and the T-cell Cytokine Profile. 1997;135-152 Springer, London, This provides a useful reminder that the neuroendocrine system plays a major, but frequently ignored, part in the functioning of the immune system.
52. Garside P, Steel M, Worthey EA, Satoskar A, Alexander J, Bluethmann H, Liew FY, Mowat AM. T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J Immunol. 154:1995;5649-5655.
53. Barone KS, Tolarova DD, Ormsby I, Doetschman T, Michael JG. Induction of oral tolerance in TGF-beta 1 null mice. J Immunol. 161:1998;154-160.
54. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:1993;263-274.
55. Pakala SV, Kurrer MO, Katz JD. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. of special interest J Exp Med. 186:1997;299-306 The authors provide a demonstration that T reg cells cannot be equated to Th2-type T cells. Compare with [56].
56. Lafaille JJ, Van de Keere F, Hsu AL, Baron JL, Hass W, Raine CS, Tonegawa S. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med. 186:1997;307-312.
57. Takeuchi M, Alard P, Streilein JW. TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells. of special interest J Immunol. 160:1998;1589-1597 This gives an indication that, like IL-10, TGF-β can modify T cell function by acting on antigen-presenting cells. Compare with [58].
58. King C, Davies J, Mueller R, Lee MS, Krahl T, Yeung B, O'Connor E, Sarvetnick N. TGF-beta 1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity. 8:1998;601-613.
59. Trembleau S, Penna G, Gregori S, Gately MK, Adorini L. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur J Immunol. 27:1997;2330-2339.
60. Stumbles P, Mason D. Activation of CD4+ T cells in the presence of a nondepleting monoclonal antibody to CD4 induces a Th2-type response in vitro. J Exp Med. 182:1995;5-13.
61. Cobbold S, Waldmann H. Infectious Tolerance. of special interest Curr Opin Immunol. 10:1998;518-524 This reviews the several ways whereby infectious tolerance can be obtained and discusses how they may mediate their function; it emphasises that many questions remain.
62. Bridoux F, Badou A, Saoudi A, Bernard I, Druet E, Pasquier R, Druet P, Pelletier L. Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines. of outstanding interest J Exp Med. 185:1997;1769-1775 This is a demonstration that Th2-type T cell responses can be subject to regulation by a TGF-β-dependent mechanism.
63. Han HS, Jun HS, Utsugi T, Yoon JW. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. J Autoimmun. 9:1996;331-339.
64. Lombardi G, Sidhu S, Batchelor R, Lechler R. Anergic T cells as suppressor cells in vitro. Science. 264:1994;1587-1589.
65. Frasca L, Carmichael P, Lechler R, Lombardi G. Anergic T cells effect linked suppression. Eur J Immunol. 27:1997;3191-3197.
66. Gleeson PA, Toh BH, van Driel IR. Organ-specific autoimmunity induced by lymphopenia. Immunol Rev. 149:1996;97-125.
67. + T cells. J Exp Med. 184:1996;19-29.
68. Buer J, Lanoue A, Franzke A, Garcia C, von Boehmer H, Sarukhan A. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J Exp Med. 187:1998;177-183.
69. Sundstedt A, Hoiden I, Rosendahl A, Kalland T, van Rooijen N, Dohlsten M. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo. J Immunol. 158:1997;180-186.
70. Read S, Mauze S, Asseman A, Coffman RL. CD38+ CD45RBlow CD4+ T cells: a T cell population with immune regulatory activities in vitro. Eur J Immunol. 1998;. in press.
71. Thornton AM, Shevach EM. CD4(+)CD25(+) immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 188:1998;287-296.